Results 231 to 240 of about 258,864 (309)

Treatment Patterns, Disease Management, and Quality of Life in Outpatients with CKD and Decreased eGFR: A Multicenter Prospective Observational Study in Greece. [PDF]

J Clin Med
Ntounousi E, Stylianou K, Marinaki S, Liakopoulos V, Lionaki S, Stefanidis I, Panagoutsos S, Goumenos D, Xidakis D, Griveas I, Chelioti E, Tzanakis I, Gourlis D, Andreadellis A, Stambolliu E, Petras D.   +15 more
europepmc   +1 more source

Chronic Kidney Disease‐Associated Pruritus Is Linked to Selective Enrichment of Taurine‐Conjugated Bile Acid Subspecies

JEADV Clinical Practice, EarlyView.
Chronic kidney disease‐associated pruritus (CKDaP) is a frequent complication of advanced CKD with an incompletely understood pathophysiology. We identified a significantly altered glycine‐to‐taurine conjugated bile acid ratio in patients with CKDaP despite unchanged total serum bile acid concentrations.
Miriam M. Düll, Manfred Rauh, Peter Dietrich, Marcel Vetter, Jonas Schmid, Thomas Mettang, Andreas E. Kremer   +6 more
wiley   +1 more source

Chronic kidney disease and cognitive decline: choroid plexus remodeling, glymphatic dysfunction, and alzheimer biomarker interpretation. [PDF]

Neurol Sci
Corrêa LMA, Oliveira da Silva R, Brandão LKV, Delmiro Silva YR, da Silva ÉVB, Tretow J, Gomes EDC, Fernandes CCS, Moreira GNCM, Zanella J.   +9 more
europepmc   +1 more source

Chronic, Environmentally Relevant PM2.5 Exposure Exacerbates Metabolic Dysfunction‐Associated Steatotic Liver Disease and Early‐Stage Renal Dysfunction in a Rodent Model

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT While epidemiological studies link fine particulate matter (PM2.5) exposure to metabolic dysfunction‐associated steatotic liver disease (MASLD) and renal dysfunction, a translational gap exists, as most animal models utilize acute, high‐dose exposures that poorly reflect chronic, moderate‐level human scenarios.
Yi‐Siao Chen, Hugo You‐Hsien Lin, Chien‐Tzu Lin, Si‐Hua Huang, Ming‐Lun Yeh, Ming‐Lung Yu, Jin‐Ching Lee, Yao‐Chi Chung, Wei‐Ming Li, Ching‐Chia Li, Shiu‐Feng Huang, Chia‐Hung Yen   +11 more
wiley   +1 more source

Depression in chronic kidney disease and dialysis: A psychonephrology narrative review. [PDF]

World J Nephrol
Yadav M, Kumar A, Pandey A, Singh S, Kumar R, Verma H, Mahajan S, Sharma S, Prasad P, Agarwal A.   +9 more
europepmc   +1 more source

Joint and Independent Associations of Dietary Antioxidant Intakes With Advanced Stages in Older Patients With Cardiovascular‐Kidney‐Metabolic Syndrome

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study explored the association between the composite dietary antioxidant index (CDAI) and cardiovascular‐kidney‐metabolic (CKM) progression in an older population. Using data from NHANES 2001–2020, we analyzed 4974 adults aged ≥ 60 years with CKM syndrome. The CDAI was calculated from the intake of six dietary antioxidants.
Fu‐Shan Qiu, Jian‐Chao Qi, Mei‐Zhu Lin, Jun‐Hua Ke   +3 more
wiley   +1 more source

Elevated Lipoprotein(a) is Independently Associated with Deep Cerebral Microbleeds in Patients with Chronic Kidney Disease: A Retrospective Observational Study. [PDF]

Int J Gen Med
Fang B, Lan J, Zhang W, Wang R.
europepmc   +1 more source

The Association Between Stress‐Induced Hyperglycemia Ratio and Increased Urinary Albumin Excretion in Patients With Hypertension: A Population‐Based Study

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The stress hyperglycemia ratio (SHR), a novel marker reflecting relative hyperglycemia, has been increasingly recognized for its prognostic value in cardiovascular and metabolic diseases. However, its association with early renal damage in hypertensive patients remains underexplored.
Kai‐Jun Zhang, Yun Lan, Wen‐Feng Zeng, Rong‐Ting Zhang, Zhi‐Yi Ma, Xin Zou   +5 more
wiley   +1 more source

CKD disrupts cardiac energy metabolism and aggravates cardiac inflammation, oxidative stress, and dysfunction post-infarction. [PDF]

Cardiovasc Res
Schulte C, Wollenhaupt J, Hourtz S, Harlacher E, Moellmann J, Cruz Junho CV, Kohlhaas M, Jankowski V, Jin H, Reugels M, Maryam S, Hausmann F, Wong DWL, van der Vorst EPC, Berger M, Vondenhoff S, Kurt B, Ghesquière B, Mueller C, Schulze-Späte U, Schmitt-Kopplin P, Biessen EAL, Prates-Roma L, Biener M, Giannitsis E, Katus HA, Schunk S, Fliser D, Marx-Schütt K, Lehrke M, Kramann R, Kahles F, Boor P, Goettsch C, Hayat S, Jankowski J, Maack C, Döring Y, Marx N, Noels H.   +39 more
europepmc   +1 more source

Stage‐Dependent Prognostic Value of the Joint MASLD–NAFLD Fibrosis Score Phenotype Across the Cardiovascular–Kidney–Metabolic Syndrome Continuum: A Retrospective NHANES Cohort Analysis, 1999–2018

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The cardiovascular–kidney–metabolic (CKM) framework and metabolic dysfunction–associated steatotic liver disease (MASLD) describe a shared clinical continuum, but the prognostic value of joint fatty liver index (FLI)–NAFLD fibrosis score (NFS) phenotypes across CKM stages is uncertain.
Yi‐Fei Wang, Jian‐Li Zhang, Yun‐Fei Wang, Jun‐Peng Xiong, Rong‐Hui Yu, Ze‐Ping Hu   +5 more
wiley   +1 more source